Publications by authors named "Tyler C Beck"

Claim this Profile
K
Kappa opioid agonists in the treatment of itch: just scratching the surface?
Tyler C Beck, Elena M Wilson, Erik Wilkes, Lara Wine Lee, Russell Norris

Itch (Phila)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin G4-Related Disease-Associated Dermatitis with Pruritus: A Positive Response to Dupilumab.
Tyler C Beck, John Plante, India Robinson, Katsiaryna Khatskevich, Jessica A Forcucci

Life (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diet, sleep, and exercise in inflammatory skin diseases.
Shawn Afvari, Tyler C Beck, Maryia Kazlouskaya, Ryan Afrahim, Manuel Valdebran

Our Dermatol Online· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular and Molecular Mechanisms of MEK1 Inhibitor-Induced Cardiotoxicity.
Tyler C Beck, Dimitrios C Arhontoulis, Jordan E Morningstar, Nathaniel Hyams, Andrew Stoddard

JACC CardioOncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Pharmacokinetic Prediction Platforms in the Design of Optimized Anti-Cancer Drugs.
Tyler C Beck, Kendra Springs, Jordan E Morningstar, Catherine Mills, Andrew Stoddard

Molecules· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DCHS1, Lix1L, and the Septin Cytoskeleton: Molecular and Developmental Etiology of Mitral Valve Prolapse.
Kelsey S Moore, Reece Moore, Diana B Fulmer, Lilong Guo, Cortney Gensemer, Tyler C Beck

J Cardiovasc Dev Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitral Valve Prolapse Induces Regionalized Myocardial Fibrosis.
Jordan E Morningstar, Cortney Gensemer, Reece Moore, Diana Fulmer, Tyler C Beck

J Am Heart Assoc· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs.
Tyler C Beck, Kyle R Beck, Jordan Morningstar, Menny M Benjamin, Russell A Norris

Pharmaceuticals (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biased Opioid Receptor Ligands: Gain without Pain.
Tyler C Beck, Thomas A Dix, Russell A Norris

Trends Endocrinol Metab· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine.
Tyler C Beck, Kyle R Beck, Calvin B Holloway, Richard A Hemings, Thomas A Dix

Front Pharmacol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting peripheral ϰ-opioid receptors for the non-addictive treatment of pain.
Tyler C Beck, Thomas A Dix

Future Drug Discov· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-addictive orally-active kappa opioid agonists for the treatment of peripheral pain in rats.
Tyler C Beck, Carmela M Reichel, Kristi L Helke, Sanat S Bhadsavle, Thomas A Dix

Eur J Pharmacol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diuretic Activity of a Novel Peripherally-Restricted Orally-Active Kappa Opioid Receptor Agonist.
Tyler C Beck, Matthew A Hapstack, Gautam S Ghatnekar, Thomas A Dix

Med Sci (Basel)· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Peripheral Kappa Opioid Receptors for the Treatment of Chronic Pain: Review Article.
Tyler C Beck, Thomas A Dix, Carmela M Reichel

Adv Nanomed Nanotechnol Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Potential of Kappa Opioid Agonists.
Tyler C Beck, Matthew A Hapstack, Kyle R Beck, Thomas A Dix

Pharmaceuticals (Basel)· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis